Inventiva S.A. (EPA:IVA)
France · Delayed Price · Currency is EUR 2.870
-0.085 (-2.88%)
Sep 29, 2026, 5:35 PM CET
Inventiva Market Cap
Inventiva has a market cap or net worth of €698.21 million as of September 29, 2026. Its market cap has decreased by -0.61% in one year.
Market Cap
698.21M
Enterprise Value
829.26M
Revenue
2.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.87
ChartMarket Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 134.55M to 698.21M, an increase of 418.94%. That is a compound annual growth rate of 18.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 698.21M | -7.35% |
| Dec 31, 2025 | 753.62M | 261.37% |
| Dec 31, 2024 | 208.54M | -1.39% |
| Dec 29, 2023 | 211.49M | 12.21% |
| Dec 30, 2022 | 188.49M | -60.71% |
| Dec 31, 2021 | 479.69M | 6.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.42B |
| MedinCell | 856.85M |
| DBV Technologies | 613.14M |
| Valneva SE | 525.32M |
| Genfit | 492.24M |
| Valerio Therapeutics Société anonyme | 292.68M |
| Transgene | 199.93M |
| Innate Pharma | 133.06M |